USPTO serial 79296907
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and veterinary preparations and substances for the treatment of and protection against infectious diseases; pharmaceutical and veterinary preparations and substances for the treatment of and protection against infectious and autoimmune disease; pharmaceutical and veterinary preparations and substances for the treatment of or protection against viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders; prophylactic pharmaceutical and veterinary preparations and substance for the treatment of infectious and autoimmune diseases; prophylactic pharmaceutical and veterinary preparations and substances against infectious and autoimmune diseases; vaccines, prophylactic vaccines, therapeutic vaccines; contraceptive preparations and substances | ACTIVE | — |
| 010 | Surgical, medical, dental and veterinary apparatus and instruments, namely, needle-free drug administration devices sold empty; drug delivery devices for delivery of drugs; drug delivery apparatus for medical use, delivered through pressure; needle-free drug delivery systems sold empty; actuator devices drug delivery systems, namely, medical solid dose injector sold empty for injecting pharmaceutical and veterinary preparations into the skin; drug cassettes in the nature of drug and vaccine delivery systems sold empty; medical injectors, needle-free injectors sold empty; drug delivery devices, namely, medical injectors, needle-free injectors and parts and fittings therefore sold empty; actuator devices for use in drug delivery devices for use, namely, handheld spring-powered devices and handheld gas-powered devices, all in the nature of needle-free injection systems for injecting pharmaceutical and veterinary preparations into the skin sold empty; drug cassettes for use in drug delivery devices to contain pharmaceutical preparations and substances for therapeutic, prophylactic and diagnostic use; parts and fittings for all the aforesaid goods | ACTIVE | — |
| 042 | Medical and veterinary research and development services; medical and veterinary device development services; pharmaceutical drug and vaccine development services; pharmaceutical drug and vaccine delivery system development services; preparation and/or formulation of pharmaceuticals, namely, pharmaceutical drug and vaccine development services; scientific research into vaccines; medical and veterinary device and product testing services; provision of information relating to the aforesaid services, namely, drug and vaccine development and drug and vaccine delivery technology; consultancy in relation to the aforesaid services, namely, drug and vaccine development and drug and vaccine delivery technology | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 3, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 12, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 12, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 26, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 26, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 10, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 10, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 8, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 21, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 21, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 21, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 7, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 1, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 31, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 31, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 20, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 29, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 29, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 10, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 9, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 6, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 2, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 2, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 29, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |